Trends in antimicrobial resistance of Pseudomonas aeruginosa, Escherichia coli and Bacteroides fragilis (1997-2001);Evolución de la resistencia antibiótica de Pseudomonas aeruginosa, Escherichia coli y Bacteroides fragilis (1997-2001)

Revista Espanola de Quimioterapia

Volumn 16, Issue 4, 2003, Pages 421-427

  Garcia Rodriguez J A ^a   Casal, M ^b   Rodriguez F ^b   Garcia C ^c   Fernandez C ^d   Torroba, L ^e   Zaballa, A ^e   Rodriguez J ^f,r   Lopez De Goicoechea M J ^g   Martin R ^h   Marco, M L ⁱ   Borrell, N ^j   Llucian, R ^k   Nogueira, J M ^l   Marco, F ^m   Alberte, A ⁿ   Romero, D ^o   Lopez Brea M ^p   Picazo, J J ^q   Chaves, F ^r   Canton R ^s   Zarauz, J M ^t   Garcia J ^u   Batista, M ^v   Moreno, A ^v   Martin E ^w   Aznar, J ^x   Pinedo, A ^y   Perea, E ^z   more..

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c Pediatric Nutrition Research Group Health Research Institute of Santiago de Compostela   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e Universidad Pública de Navarra   (Spain)

^f HOSPITAL SAN AGUSTÍN   (Spain)

^g HOSPITAL DE GALDAKAO   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁱ HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^j HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^k HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^l HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^m HOSPITAL CLÍNIC   (Spain)

ⁿ HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^o Hospital Alarcos   (Spain)

^p HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^q HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^r HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^s HOSPITAL RAMÓN Y CAJAL   (Spain)

^t HOSPITAL RAFAEL MÉNDEZ   (Spain)

^u HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^v HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^w HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^x HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^y HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^z HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

more..

Author keywords

Bacteroides fragilis; Escherichia coli; Pseudomonas aeruginosa; Susceptibility

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEROIDES FRAGILIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; ESCHERICHIA COLI; HOSPITAL; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; NONHUMAN; PSEUDOMONAS AERUGINOSA; SPAIN; DRUG EFFECT; TIME;

ANTI-BACTERIAL AGENTS; BACTEROIDES FRAGILIS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; PSEUDOMONAS AERUGINOSA; TIME FACTORS;

EID: 4644302458     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jones, R.N. The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance. Diagn Microbiol Infect Dis 1996; 25: 153-161.
2. Archibald, L., Phillips, L., Monnet, D., McGowan, J.E., Jr., Tenover, F., Gaynes, R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-215.
3. Diekema, D.J., Pfaller, M.A., Jones, R.N. y cols. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. Int J Antimicrob Agents 2000; 13: 257-271.
4. Fluit, A.C., Jones, M.E., Schmitz, F.J., Acar, J., Gupta, R., Verhoef, J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 2000; 30: 454-460.
5. García-Rodríguez, J.A., Jones, R.N. Antimicrobial resistance in gram-negative isolates from European intensive care units: Data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme. J Chemother 2002; 14: 25-32.
6. Jarvis, W.R., Martone, W.J. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992; 29 (Suppl. A): 19-24.
7. Betriu, C., Campos E., Cabronero, C., Rodríguez-Avial, C., Picazo, J.J. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents. Antimicrob Agents Chemother 1990; 34: 671-673.
8. Snydman, D.R., Jacobus, N.V., McDermott, L.A. y cols. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob Agents Chemother 1999; 43: 2417-2422.
9. García-Rodríguez, J.A., García, J.E., García, M.I., Trujillano, I. Infecciones nosocomiales por anaerobios. Enferm Infecc Microbiol Clin 1995; 13: 429-434.
10. Fluit, A., Jones, M.E., Schmitz, F.J., Gupta, R., Acar, J., Verhoef, J. Antimicrobial resistance among community acquired pneumonia isolates in Europe: Results from the Sentry Antimicrobial Surveillance Program. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California 1998; Abst. E13.
11. Fluit, A.C., Schmitz, F.J., Jones, M.E., Acar, J., Gupta, R., Verhoef, J. Antimicrobial resistance among community-acquired pneumonia isolates in Europe: First results from the SENTRY antimicrobial surveillance program 1997. SENTRY Participants Group. Int J Infect Dis 1999; 3: 153-156.
12. Fluit, A.C., Jones, M.E., Schmitz, F.J., Acar, J., Gupta, R., Verhoef, J. Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: Results from the SENTRY Antimicrobial Surveillance Program 1997. Antonie Van Leeuwenhoek 2000; 77: 147-152.
13. Sader, H.S., Jones, R.N., Winokur, P.L., Pfaller, M.A., Doern, G.V., Barrett, T. Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: Results from the SENTRY Antimicrobial Surveillance Program (1997). Clin Microbiol Infect 1999; 5: 478-487.
14. Sader, H.S., Pfaller, M.A., Jones, R.N. y cols. Bacterial pathogens isolated from patients with bloodstream infections in Latin America, 1997: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program. Braz J Infect Dis 1999; 3: 97-110.
15. National Committee for Clinical Laboratory Standards (NCCLS). Minimum Inhibitory Concentration (MIC) Interpretative Standards M7-A4. NCCLS, Villanova, Pa 1997; Document 2.
16. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing: Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Supplement M100-S8 (supplement tables to approved standard M100). NCCLS, Wayne, PA 1998.
17. National Conmttee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically: Approved standard, 5th edition. Document M7-A5. NCCLS, West Valley Road, Wayne, PA 2000.
18. National Committee for Clinical Laboratory Standards (NCCLS). Approved Standard M11-A4. Methods for antimicrobial susceptibility testing of anaerobic bacteria. NCCLS, Wayne, PA 1997.
19. Gobernado, M., Bouza, E., Perea, E., Álvarez-Bravo, J., García Rodríguez, J.A. Estudio multicéntrico nacional de la actividad in vitro de piperacilina-tazobactam. Rev Esp Quimioterap 1998; 11: 139-146.
20. García-Rodríguez, J.A., Trujillano, I. Segundo estudio multicéntrico de la sensibilidad in vitro a piperacilina-tazobactam. Rev Esp Quimioterap 2002; 15: 169-175.
21. Bouza, E., García-Garrote, E, Cercenado, E. y cols. Pseudomonas aeruginosa: Estudio multicéntrico en 136 hospitales españoles. Rev Esp Quimioterap 2003; 16: 41-52.
22. García, M., Rodríguez, J., Brezmes, M. Escherichia coli resistentes a amoxicilina-ácido clavulánico en infecciones del tracto urinario. Rev Esp Quimioterap 1996; 9 (Supl. 4): 192.
23. Asensio, A., Cantón, R., Vaqué, J., Rosselló, J., Arribas, J.L. Utilización de los antimicrobianos en los hospitales españoles (EPINE 1990-1999). Med Clin (Barc) 2002; 118: 731-736.